Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

VanEck Vectors Biotech ETF (BBH)

117.78
Delayed Data
As of May 25
 -0.22 / -0.19%
Today’s Change
95.77
Today|||52-Week Range
123.15
+9.49%
Year-to-Date

Investment Objective

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVISä US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

No recent news for VanEck Vectors Biotech ETF.

Performance

1 month-1.11% 3 years+10.22%
3 months-0.43% 5 years+20.98%
1 year+9.78% Since inception+25.14%
Data through 05/25/2017

Quote Details

Previous close$118.00
Open day’s range117.77 – 118.37
Net asset value (NAV)118.04 (05/24/2017)
Daily volume135,873
Average volume (3 months)45,645
Data as of 3:59pm ET, 05/25/2017

Peer Comparisonvs. Health ETFs

 BBHCategory
Performance 5-yr return+20.98%+16.30%
Expense Gross exp ratio0.40%1.32%
Risk 5 year sharpe ratio1.021.08
Net assets$682.4M$3.0B
Average market cap$36.0B$28.8B
Average P/E19.323.8
Dividend / Share--0.28%

Competitors

XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
VHT Vanguard Health Care Index Fund ETF Shar...

Holdings

Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
AMGN Amgen12.11%
CELG Celgene11.13%
GILD Gilead Sciences10.21%
AGN Allergan8.56%
BIIB Biogen6.13%
VRTX Vertex Pharmaceuticals Inc5.53%
ILMN Illumina Inc5.03%
Q Quintiles IMS Holdings Inc4.76%
BMRN Biomarin Pharmaceutical Inc4.59%
REGN Regeneron Pharmaceuticals4.55%